Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Reexamination Certificate
2006-01-04
2010-02-16
Haghighatian, Mina (Department: 1616)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
C424S489000, C424S499000, C514S002600, C514S951000
Reexamination Certificate
active
07662403
ABSTRACT:
There is provided a powder formulation for nasal delivery including a protein having a molecular weight of 10 kDa or greater and chitosan or a derivative thereof or a salt of chitosan or a salt of a derivative of chitosan. Preferably the protein is human growth hormone.
REFERENCES:
patent: 5840341 (1998-11-01), Watts et al.
patent: 5863554 (1999-01-01), Illum
patent: 6391318 (2002-05-01), Illum
patent: 2001/0053359 (2001-12-01), Illum
patent: 2005/0271728 (2005-12-01), Nomura et al.
patent: 0 943 326 (1999-09-01), None
patent: 07-118170 (1995-05-01), None
patent: WO 90/09780 (1990-09-01), None
patent: WO 96/05810 (1996-02-01), None
patent: WO 96/10421 (1996-04-01), None
patent: WO 9620730 (1996-07-01), None
patent: WO 97/16208 (1997-05-01), None
patent: WO 97/20576 (1997-06-01), None
patent: WO 98/01160 (1998-01-01), None
patent: WO 98/01161 (1998-01-01), None
patent: WO 9830207 (1998-07-01), None
patent: WO 99/01498 (1999-01-01), None
patent: WO 99/27960 (1999-06-01), None
patent: WO 03/043574 (2003-05-01), None
Lacy et al, Drug Information Handbook, 1993, pp. 436-437.
Aspden et al, Journal of Pharmaceutical Sciences, vol. 86, No. 4, Apr. 1997, pp. 509-513 (XP 000683471).
Illum et al., “Nasal drug delivery—possibilities, problems and solutions”,Journal of Controlled Release, vol. 87, pp. 187-198 (2003).
Aspden et al., “Chitosan as a nasal delivery system: Evaluation of the effect of chitosan on mucociliary clearance rate in a frog palate model”,International Journal of Pharmaceutics, vol. 122, pp. 69-78 (1995).
Illum et al., “Chitosan as a Novel Nasal Delivery System for Peptide Drugs”,Pharmaceutical Research, vol. 11, pp. 1186-1189 (1994).
Davis et al., “Absorption Enhancers for Nasal Drug Delivery”,Clinical Pharmacokinetics, vol. 42, pp. 1107-1128 (2003).
Martindale (The Complete Drug Reference), 33rdedition,Pharmaceutical Press, London, pp. 1291 and 750 (2002).
Illum et al., “Novel chitosan-based delivery systems for the nasal administration of a LHRH-analogue”,STP Pharma Sciences, vol. 10, pp. 89-94 (2000).
Illum, “Nasal drug delivery: new developments and strategies”,Drug Discovery Today, vol. 7, pp. 1184-1189 (2002).
Rouan, “Developments in Protein Drug Delivery,”Modern Pharmaceutics, pp. 866-867, 3rdEdition, Banker and Rhodes (eds.), Marcel Dekker, New York (1996).
Winters et al., “Precipitation of Proteins in Supercritical Carbon Dioxide”,Journal of Pharmaceutical Sciences, vol. 85, pp. 586-594 (1996).
Subramaniam et al., “Pharmaceutical Processing with Supercritical Carbon Dioxide”,Journal of Pharmaceutical Sciences, vol. 86, pp. 885-890 (1997).
Palakodaty et al., “Phase Behavioral Effects on Particle Formation Processes Using Supercritical Fluids”,Pharmaceutical Research, vol. 16, pp. 976-985 (1999).
Nucci et al., “The therapeutic value of poly(ethylene glycol)-modified proteins”,Advanced Drug Delivery Reviews, vol. 6, pp. 133-151 (1991).
Roberts, “Chitin Chemistry”, Macmillan Press Ltd., London (1992)—too Voluminous to Include.
Carstensen, Ph.D., “Powder Dosage Forms, Densities and Blending”,Pharmaceutical Principles of Solid Dosage Forms, Chapters 2 and 6, Technomic Publishing Co., Inc., Lancaster, PA (1993).
O'Connor, Ph.D., “Powders”,Remington: The Science and Practice of Pharmacy, 20thEd., Chapter 37, Lipincott, Williams and Wilkins, Baltimore (2000).
Broadhead et al., “The Spray Drying of Pharmaceuticals”,Drug Development and Industrial Pharmacy, vol. 18, pp. 1169-1206 (1992).
“Handbook of Pharmaceutical Excipients”, 4thEd., Pharmaceutical Press, London, Rowe et al. (eds) (2003)—Table of Contents only.
“Goodman & Gilman's The Pharmacological Basis of Therapeutics”, 9thEd., McGraw-Hill, New York (1995)—Table of Contents only.
Hinchcliffe et al., “Intranasal insulin delivery and therapy”,Advanced Drug Deliver Reviews, vol. 35, pp. 199-234 (1999).
Cheng Yu-Hui
Dyer Ann Margaret
Smith Alan
Watts Peter James
Archimedes Development Limited
Haghighatian Mina
Panitch Schwarze Belisario & Nadel LLP
LandOfFree
Pharmaceutical formulations for intranasal administration of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical formulations for intranasal administration of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical formulations for intranasal administration of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4179590